Terms: = Pancreatic cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
69 results:
1. Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.
Jiang L; Qin J; Dai Y; Zhao S; Zhan Q; Cui P; Ren L; Wang X; Zhang R; Gao C; Zhou Y; Cai S; Wang G; Xie W; Tang X; Shi M; Ma F; Liu J; Wang T; Wang C; Svrcek M; Bardier-Dupas A; Emile JF; de Mestier L; Bachet JB; Nicolle R; Cros J; Laurent-Puig P; Wei M; Song B; Jing W; Guo S; Zheng K; Jiang H; Wang H; Deng X; Chen H; Tian Q; Wang S; Shi S; Jin G; Yin T; Fang H; Chen S; Shen B
Nat Med; 2024 Mar; 30(3):749-761. PubMed ID: 38287168
[TBL] [Abstract] [Full Text] [Related]
2. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of pancreatic cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract] [Full Text] [Related]
3. Age-specific cardiovascular disease-related mortality among patients with major gastrointestinal cancers: A SEER population-based study.
Liu G; Zhang BF
Cancer Med; 2023 Aug; 12(16):17253-17265. PubMed ID: 37387603
[TBL] [Abstract] [Full Text] [Related]
4. [Exocrine pancreatic cancer - what is new in the update of the S3 guideline?].
Seufferlein T; Kestler A
Dtsch Med Wochenschr; 2023 Jun; 148(12):737-743. PubMed ID: 37257475
[TBL] [Abstract] [Full Text] [Related]
5. Magnetic resonance elastography-derived stiffness: potential imaging biomarker for differentiation of benign and malignant pancreatic masses.
Liu D; Chen J; Zhang Y; Dai Y; Yao X
Abdom Radiol (NY); 2023 Aug; 48(8):2604-2614. PubMed ID: 37237155
[TBL] [Abstract] [Full Text] [Related]
6. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
Graus MUJE; de Hingh IHJT; Besselink MG; Bruno MJ; Wilmink JW; de Meijer VE; van Velthuysen MF; Valkenburg-van Iersel LBJ; van der Geest LGM; de Vos-Geelen J; ; ;
HPB (Oxford); 2023 Oct; 25(10):1195-1202. PubMed ID: 37236831
[TBL] [Abstract] [Full Text] [Related]
7. Impact of COVID-19 lockdowns on postoperative morbidity after hepatectomy: A propensity-score matching study on a national French database.
Nassar A; Tzedakis S; Marchese U; Dhote A; Dallel MS; Naveendran G; Gaillard M; Coriat R; Marty JR; Fuchs B; Fuks D
Surgery; 2023 Aug; 174(2):196-202. PubMed ID: 37150714
[TBL] [Abstract] [Full Text] [Related]
8. Validation of a Resectability Scoring System for Prediction of pancreatic Adenocarcinoma Surgical Outcomes.
Toesca DAS; Susko M; von Eyben R; Baclay JRM; Pollom EL; Jeffrey RB; Poullos PD; Poultsides GA; Fisher GA; Visser BC; Koong AC; Feng M; Chang DT
Ann Surg Oncol; 2023 Jun; 30(6):3479-3488. PubMed ID: 36792768
[TBL] [Abstract] [Full Text] [Related]
9. The Global, Regional and National Burden of pancreatic cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019.
Jiang W; Xiang C; Du Y; Li X; Zhou W
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674311
[TBL] [Abstract] [Full Text] [Related]
10. Effect of omega-3 supplementation on the nutritional status of patients with pancreatic cancer: A protocol for systematic review of clinical trials.
Pires LBC; Salaroli LB; Lopes-Júnior LC
Medicine (Baltimore); 2022 Dec; 101(50):e31262. PubMed ID: 36550825
[TBL] [Abstract] [Full Text] [Related]
11. Role of N
Ye T; Wang J; Zhao H; Zhao G; Li P
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36367195
[TBL] [Abstract] [Full Text] [Related]
12. Surgical outcomes and prognostic factors of distal common bile duct adenocarcinoma: chronological analysis in a single high-volume institutional experience.
Jung JH; Yoon SJ; Lee OJ; Shin SH; Han IW; Heo JS
BMC Surg; 2022 Jul; 22(1):258. PubMed ID: 35787702
[TBL] [Abstract] [Full Text] [Related]
13. Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade.
Alausa A; Lawal KA; Babatunde OA; Obiwulu ENO; Oladokun OC; Fadahunsi OS; Celestine UO; Moses EU; Akaniro IR; Adegbola PI
Pharmacol Res; 2022 Jul; 181():106264. PubMed ID: 35597384
[TBL] [Abstract] [Full Text] [Related]
14. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
[TBL] [Abstract] [Full Text] [Related]
15. The role of cytology in the investigation and management of pancreatobiliary lesions with a transition towards a standardised reporting system: An institutional perspective.
Hanks M; Ryder S; Zaitoun A
Cytopathology; 2022 May; 33(3):293-300. PubMed ID: 35231151
[TBL] [Abstract] [Full Text] [Related]
16. Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.
Matsubayashi H; Higashigawa S; Kiyozumi Y; Oishi T; Sasaki K; Ishiwatari H; Imai K; Hotta K; Yabuuchi Y; Ishikawa K; Satoh T; Ono H; Todaka A; Kawakami T; Shirasu H; Yasui H; Sugiura T; Uesaka K; Kagawa H; Shiomi A; Kado N; Hirashima Y; Kiyohara Y; Bando E; Niwakawa M; Nishimura S; Aramaki T; Mamesaya N; Kenmotsu H; Horiuchi Y; Serizawa M
BMC Cancer; 2022 Jan; 22(1):73. PubMed ID: 35039004
[TBL] [Abstract] [Full Text] [Related]
17. Potential advantages of robotic total gastrectomy for gastric cancer: a retrospective comparative cohort study.
Kumamoto T; Ishida Y; Igeta M; Hojo Y; Nakamura T; Kurahashi Y; Shinohara H
J Robot Surg; 2022 Aug; 16(4):959-966. PubMed ID: 34716875
[TBL] [Abstract] [Full Text] [Related]
18. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
COVIDSurg Collaborative
Lancet Oncol; 2021 Nov; 22(11):1507-1517. PubMed ID: 34624250
[TBL] [Abstract] [Full Text] [Related]
19. Early Palliative Care Is Associated With Reduced Emergency Department Utilization in pancreatic cancer.
Bevins J; Bhulani N; Goksu SY; Sanford NN; Gao A; Ahn C; Paulk ME; Terauchi S; Pruitt SL; Tavakkoli A; Rhodes RL; Kazmi SMA; Beg MS
Am J Clin Oncol; 2021 May; 44(5):181-186. PubMed ID: 33710133
[TBL] [Abstract] [Full Text] [Related]
20. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer.
Lei Y; Yu T; Li C; Li J; Liang Y; Wang X; Chen Y; Wang X
J Cell Mol Med; 2021 Jan; 25(2):1198-1206. PubMed ID: 33342045
[TBL] [Abstract] [Full Text] [Related]
[Next]